Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (43)

2018

  1. Direct medical costs and their predictors in the EMAR-II cohort: “Variability in the management of rheumatoid arthritis and spondyloarthritis in Spain”

    Reumatologia Clinica, Vol. 14, Núm. 1, pp. 4-8

2013

  1. Orthopedic surgery in rheumatoid arthritis in the era of biologic therapy

    Journal of Rheumatology, Vol. 40, Núm. 11, pp. 1850-1855

2009

  1. Treatment of refractory posterior uveitis with infliximab: A 7-year follow-up study

    Scandinavian Journal of Rheumatology, Vol. 38, Núm. 1, pp. 58-62

2008

  1. Burden of disease across chronic diseases: A health survey that measured prevalence, function, and quality of life

    Journal of Rheumatology, Vol. 35, Núm. 1, pp. 159-165

  2. Differences between rheumatology attending physicians and training residents in the management of rheumatoid arthritis in Spain

    Scandinavian Journal of Rheumatology, Vol. 37, Núm. 6, pp. 419-426

  3. Medición de la actividad en la espondilitis anquilosante

    Seminarios de la Fundacion Espanola de Reumatologia, Vol. 9, Núm. 1, pp. 59-66

  4. Observed and expected frequency of comorbid chronic diseases in rheumatic patients

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 3, pp. 418-421

  5. Prognostic factors in short-term disability due to musculoskeletal disorders

    Arthritis Care and Research, Vol. 59, Núm. 4, pp. 489-496

2007

  1. Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis

    Arthritis and Rheumatism, Vol. 56, Núm. 8, pp. 2789-2797

  2. Disminución del tiempo hasta el primer tratamiento con fármacos modificadores de la enfermedad en pacientes con artritis reumatoide

    Reumatologia Clinica, Vol. 3, Núm. 6, pp. 245-250

  3. Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction

    Osteoarthritis and Cartilage, Vol. 15, Núm. 4, pp. 475-478

  4. Musculoskeletal work disability for clinicians: Time course and effectiveness of a specialized intervention program by diagnosis

    Arthritis Care and Research, Vol. 57, Núm. 2, pp. 335-342

  5. Variability in the use of orthopedic surgery in patients with rheumatoid arthritis in Spain

    Journal of Rheumatology, Vol. 34, Núm. 7, pp. 1485-1490

2005

  1. A health system program to reduce work disability related to musculoskeletal disorders

    Annals of Internal Medicine, Vol. 143, Núm. 6

2003

  1. Costs and predictors of costs in rheumatoid arthritis: A prevalence-based study

    Arthritis Care and Research, Vol. 49, Núm. 1, pp. 64-70

  2. Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: Comment on the article by Hoffman et al [1]

    Arthritis and Rheumatism

  3. Incidencia y características de la tuberculosis en pacientes con enfermedades reumáticas autoinmunes

    Revista Clinica Espanola, Vol. 203, Núm. 4, pp. 178-182

  4. Increased risk of tuberculosis in patients with rheumatoid arthritis

    Journal of Rheumatology, Vol. 30, Núm. 7, pp. 1436-1439

  5. Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus

    Lupus, Vol. 12, Núm. 8, pp. 636-639

2002

  1. The prevalence of rheumatoid arthritis in the general population of Spain

    Rheumatology, Vol. 41, Núm. 1, pp. 88-95